- Home
- MIAX vs ARWR Comparison
MIAX vs ARWR Comparison
Compare MIAX & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIAX
- ARWR
- Stock Information
- Founded
- MIAX 2007
- ARWR 2003
- Country
- MIAX United States
- ARWR United States
- Employees
- MIAX N/A
- ARWR N/A
- Industry
- MIAX Investment Bankers/Brokers/Service
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- MIAX Finance
- ARWR Health Care
- Exchange
- MIAX Nasdaq
- ARWR Nasdaq
- Market Cap
- MIAX 3.1B
- ARWR 2.5B
- IPO Year
- MIAX 2025
- ARWR 1993
- Fundamental
- Price
- MIAX $38.24
- ARWR $29.13
- Analyst Decision
- MIAX Buy
- ARWR Strong Buy
- Analyst Count
- MIAX 6
- ARWR 8
- Target Price
- MIAX $40.00
- ARWR $47.75
- AVG Volume (30 Days)
- MIAX 794.4K
- ARWR 2.8M
- Earning Date
- MIAX 01-01-0001
- ARWR 08-07-2025
- Dividend Yield
- MIAX N/A
- ARWR N/A
- EPS Growth
- MIAX N/A
- ARWR N/A
- EPS
- MIAX 0.02
- ARWR N/A
- Revenue
- MIAX $1,255,413,000.00
- ARWR $572,976,000.00
- Revenue This Year
- MIAX N/A
- ARWR $21,619.52
- Revenue Next Year
- MIAX N/A
- ARWR N/A
- P/E Ratio
- MIAX $1,854.46
- ARWR N/A
- Revenue Growth
- MIAX 19.63
- ARWR 2816.20
- 52 Week Low
- MIAX $28.63
- ARWR $9.57
- 52 Week High
- MIAX $39.56
- ARWR $31.13
- Technical
- Relative Strength Index (RSI)
- MIAX N/A
- ARWR 70.38
- Support Level
- MIAX N/A
- ARWR $28.12
- Resistance Level
- MIAX N/A
- ARWR $31.13
- Average True Range (ATR)
- MIAX 0.00
- ARWR 1.58
- MACD
- MIAX 0.00
- ARWR 0.12
- Stochastic Oscillator
- MIAX 0.00
- ARWR 78.99
About MIAX Miami International Holdings Inc. Common Stock
Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.